Regen BioPharma Inc (RGBP)

[cvinvestor]

Sad to say, we seem to see the stock drop on news because the only thing that can create volume here is news and you have many friends and family with 10s of million of shares who want to get some of their money out of the stock.

Hence, once any type of positive news comes out, they are eager to sell and because they have millions of shares to unload, the volume of selling overtakes the buyers and down we go.

If RGBP was close to a marketable breakthrough or if they were trustworthy and good company managers, good news would bring in volumes of large scale buyers and we would go up. But there is too much bad history here that we have all witnessed.

And as many have pointed out, HemaXellerate was approved in December of 2015, ready to go to human trials. Their first FDA pipeline approval and it sits on a shelf. What large scale investor or company is going to look at that and say, wow, this company is going places...?

The only hope we have left is that ChemDiv is really a good company that has some good connections and if they really can discover and prove some very promising science, then maybe they can raise interest to move the science forward. All we have to date from within RGBP and the people they associate with is more debt and no investors.